Gratitude Spikes
Release time:
2020-08-14
Thanksgiving Peak
■ Qiubin Pharmaceutical Factory Hong Zhiwei
seems to be only in the blink of an eye. I have been in Peak for nearly 20 years. In the big family of spike, I learned a lot, gained a lot, and realized a lot.
Before the spike, I had been working in Jinhua Biochemical Pharmaceutical Factory. Although the biochemical factory had a lot of products and good benefits at that time, the factory was old and the equipment was aging, which could not meet the requirements of GMP . If it continued to develop according to the old road, it would face a serious crisis. 1988 , Jianfeng acquired the biochemical pharmaceutical factory, and a few years later, it carried out off-site transformation, updated the equipment, and adjusted the product structure. As an employee of the original chemical plant, I would like to thank the peak for giving the biochemical plant a second life, and thank the peak for another opportunity for our employees to develop themselves.
I wrote an application for joining the party as early as when I was in the biochemical factory, but it was like a stone sinking into the sea and there was no news for several years. After entering Qiubin Factory of Jianfeng Pharmaceutical, I submitted my application for joining the Party again in 2003 . Before long, Jiang Xiaohua, who was in charge of the organization of the Party branch of Qiubin factory, came to talk to me and told me that if I wanted to join the Communist Party of China, I should not only write an application, but also strengthen the study of the party's knowledge, work hard and restrain myself in behavior. After that, I participated in the training of activists organized by the party committee of the company, studied the development history of the Communist Party of China, and let me understand the sacred mission shouldered by the party members. With the help of the Party branch, my ideological consciousness has made great progress. 2006 6 May 26 , the Party branch discussed and approved my application for joining the Party. 7 September , in front of the Revolutionary Martyrs Monument, I solemnly swore to become a member of the Communist Party of China with more than 20 colleagues from my brother units. Gratitude spike, let me grow in thought.
At the peak, I have participated in many activities. The most unforgettable one is the "Commemorating the 40th Anniversary of the Listing of Peak Stock 20#" gala held in 2013 8 . Because I had previous experience in performing sketches, I was informed to prepare the program as early as the end of 2012 . After more than half a year of careful conception, I wrote the first draft of the sketch "days of our lives" and solicited opinions from many parties. Finally, I started rehearsing in , 2013 , , 6, . The Akohama Factory Office helped me find actors, rehearsal venues and props, and we rehearsed earnestly. Unexpectedly, three days before the performance, Li Ziqiang, deputy secretary of the group's party committee, called and asked to revise the script. All of a sudden, I felt that my head was big-the frame of the sketch was basically fixed, and the actors were almost running in. It was not easy to start over. Mr. Li said that the original work did not reflect the development and changes of the company's listing for 20 years, was immature and could not be staged, and proposed amendments. With Li's general advice, the three of us actors worked overtime and finally took a brand-new work to the stage three days later. The applause and laughter of the audience made us understand that our efforts were not in vain. Thanks to the peak, thanks to all the leaders and colleagues who have supported and helped me, so that I can show my wonderful side on the stage of the peak.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31